STAT1 and neoplasm: Interestingly, the class I HDACi has been shown to inhibit iNOS, COX2, and arginase-1 in the MDSCs of tumor-bearing animals, in addition to enhancing the effectiveness of PD-1 inhibition to abrogate lung and renal tumor formation [229], which might be a product of STAT1 pathway inhibition.